Risk of cancer in symptomatic postmenopausal women with endometrial polyps at scan

Journal of Obstetrics and Gynaecology

Volumn 28, Issue 5, 2008, Pages 522-525

  Kassab, A ^a   Trotter, P ^a   Fox, R ^a,b  

^a MUSGROVE PARK HOSPITAL   (United Kingdom)

^b TAUNTON AND SOMERSET HOSPITAL   (United Kingdom)

Author keywords

Endometrial cancer; Endometrial hyperplasia; Endometrial polyp

Indexed keywords

ADULT; AGED; ARTICLE; CANCER REGISTRY; CANCER RISK; DISEASE COURSE; ENDOMETRIUM CANCER; ENDOMETRIUM HYPERPLASIA; ENDOMETRIUM POLYP; ENDOSCOPIC SURGERY; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MEDICAL RECORD; MICROSCOPY; OUTPATIENT; POSTMENOPAUSE; PRECANCER; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; ENDOMETRIAL HYPERPLASIA; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; MIDDLE AGED; POLYPS; POSTMENOPAUSE; RISK ASSESSMENT; RISK FACTORS;

EID: 53849102192     PISSN: 01443615     EISSN: 13646893     Source Type: Journal    
DOI: 10.1080/01443610802097625     Document Type: Article

References (11)

1. Ashelby L, Trotter P, Fox R. 2005. ICP application - postmenopausal bleeding. Journal of Integrated Care 9:85-87.
2. Bakour SH, Khan KS, Gupta JK. 2002. The risk of premalignant and malignant pathology in endometrial polyps. Acta Obstetricia et Gynecologica Scandinavica 81:182-183.
3. Ben-Arie A, Goldchmit C, Laviv Y, Levy R, Caspi B, Huszar M. 2004. The malignant potential of endometrial polyps. European Journal of Obstetrics and Gynecology and Reproductive Biology 115:206-210.
4. Clevenger-Hoeft M, Syrop CH, Stovall DW, Van Voorhis BJ. 1999. Sonohysterography in premenopausal women with and without abnormal bleeding. Obstetrics and Gynecology 94:516-520.
5. Kurman RJ, Norris HJ. 1982. Evaluation of criteria for distinguishing atypical endometrial hyperplasia from well-differentiated carcinoma. Cancer 49:2547-2559.
6. McGurgan P, Taylor LJ, Duffy SR, O'Donovan PJ. 2006. Does tamoxifen therapy affect the hormone receptor expression and cell proliferation indices of endometrial polyps? An immunohistochemical comparison of endometrial polyps from postmenopausal women exposed and not exposed to tamoxifen. Maturitas 54:252-259.
7. Muzaffar M, Akhtar KA, Yasmin S, Mahmood-Ur-Rehman, Iqbal W, Khan MA. 2005. Menstrual irregularities with excessive blood loss: a clinico-pathological correlation. Journal of Park Medical Association 55:486-489.
8. Savelli L, De Iaco P, Santini D, Rosati F, Ghi T, Pignotti E. 2003. Histopathologic features and risk factors for benignity, hyperplasia, and cancer in endometrial polyps. American Journal of Obstetrics and Gynecology 188:927-931.
9. Silverberg SG, Kurman RJ. 1992. Tumors of the uterine corpus and gestational trophoblastic disease. In: Rosai J, Aovin L, editors. Atlas of tumor pathology. Vol 3. Washington, DC: Armed Forces Institute of Pathology. pp 113-151.
10. Tjarks M, Van Voorhis BJ. 2000. Treatment of endometrial polyps. Obstetrics and Gynecology 96:886-889.
11. Van den Bosch T, Van Schoubroeck D, Ameye L, De Brabanter J, Van Huffel S, Timmerman D. 2003. Ultrasound assessment of endometrial thickness and endometrial polyps in women on hormonal replacement therapy. American Journal of Obstetrics and Gynecology 188:1249-1253.